The effects of phospholipid molecular species on cholesterol crystallization in model biles: the influence of phospholipid head groups.
OBJECTIVE
Variations in the molecular species of biliary phospholipids have been shown to exert major effects on cholesterol solubility and carriers in model and human biles. The aim of this study was to explore systematically the effects of various phospholipid head groups on the cholesterol crystallization process in model biles.


METHODS
Three different control model biles were prepared using varying proportions of egg lecithin, cholesterol and Na taurocholate. In the test biles, 20% of the egg lecithin was replaced with synthetic phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol or phosphatidylcholine, keeping the phospholipid acyl chains and other biliary lipids constant in each experiment.


RESULTS
Phosphatidylserine and phosphatidylglycerol significantly prolonged the crystal observation time, from 2 days to 10 and 6 days, respectively (p<0.02), while phosphatidylethanolamine had little and phosphatidylcholine no effect. The crystal growth rate was significantly slowed down with 20% phospholipid replacement in the following order: phosphatidylglycerol >phosphatidylserine >phosphatidylethanolamine. The total crystal mass after 14 days, as measured by chemical analysis, was reduced by 59% with phosphatidylserine (p<0.05), and by 73% with phosphatidylglycerol (p<0.05); while phosphatidylethanolamine had little effect. The precipitable cholesterol crystal fractions after 14 days were significantly reduced with phosphatidylserine (54%) and phosphatidylglycerol (37%), but not with phosphatidylethanolamine or phosphatidylcholine.


CONCLUSIONS
Variations in the head groups of biliary phospholipids may markedly slow down the cholesterol crystallization process in model biles.
Department of Gastroenterology, Tel-Aviv Sourasky Medical Center, Ichilov Hospital, Israel.
Y
Y
Ringel
G J
GJ
Sömjen
F M
FM
Konikoff
R
R
Rosenberg
M
M
Michowitz
T
T
Gilat
D001646:Bile / Q000502:physiology*; D002784:Cholesterol / Q000737:chemistry*; D003460:Crystallization; D006801:Humans; D007700:Kinetics; D008954:Models, Biological; D010713:Phosphatidylcholines / Q000737:chemistry; D010715:Phosphatidylglycerols / Q000737:chemistry; D010718:Phosphatidylserines / Q000737:chemistry; D010743:Phospholipids / Q000737:chemistry*; D013656:Taurocholic Acid / Q000737:chemistry*; D013997:Time Factors
D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; D010718:Phosphatidylserines; D010743:Phospholipids; D013656:Taurocholic Acid; D002784:Cholesterol